<DOC>
	<DOCNO>NCT02424006</DOCNO>
	<brief_summary>In study safety effectiveness bioengineered cornea comprise interpenetrate network recombinant human type III collagen synthetic phospholipid - phosphorylcholine - tested patient corneal scar ( leukoma ) infection , trauma keratoconus . Control group consist patient condition undergo corneal transplantation - current standard care .</brief_summary>
	<brief_title>Safety Effectiveness RHCIII-MPC Biosynthetic Cornea Patients Requiring Anterior Lamellar Keratoplasty</brief_title>
	<detailed_description>Recently develop pass extensive pre-clinical test collagen-phosphorylcholine ( RHCIII-MPC ) corneal substitute implant patient 's corneas corneal scar ( leukoma ) develop infection , trauma keratoconus use anterior lamellar keratoplasty technique , i.e . patient 's diseased anterior part cornea remove , either manually assistance femtosecond laser , substitute propose transparent implant . Control patient condition graft human donor cornea use surgical technique . The investigator test safety effectiveness develop biosynthetic cornea . Overall 20 patient plan recruit . They randomize two group - 10 patient undergo RHCIII-MPC cornea implantation , another 10 impanted human donor cornea . The patient follow-uped 12 month .</detailed_description>
	<criteria>Subjects must sign give copy write Informed Consent form . Subjects best correct distance visual acuity +1.0 LogMAR bad result corneal scar due infection , injury keratoconus operative eye . Subjects must willing able return schedule followup examination 12 month surgery . Subjects severe lifethreatening systemic disease . Subjects uncontrolled hypertension . Subjects uncontrolled diabetes insulindependent diabetes . Subjects glaucoma either eye . Subjects mark microphthalmos aniridia either eye . Subjects serious ocular pathology , serious ocular complication time surgery underlie serious medical condition , base investigator 's medical judgment . Subjects lactate plan become pregnant course clinical investigation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>keratoplasty</keyword>
	<keyword>bioengineered cornea</keyword>
	<keyword>donor cornea</keyword>
</DOC>